SWK vs TCRX · P/E 34, rev $7.81B vs rev $2.0M
Stanley Black & Decker Inc (SWK) versus Tscan Therapeutics Inc (TCRX) — a side-by-side from cached financials, not a winner call.
Stanley Black & Decker Inc (SWK) is a tools & accessories company listed on NYSE.
Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
Latest reported SWK revenue for 2026-07-04 was $7.81B. Net income was $410.9M. SWK currently screens at market cap $12.82B and trailing P/E 33.8.
Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.
SWK currently screens at market cap $12.82B and trailing P/E 33.8. TCRX currently screens at market cap $62.1M.
Not investment advice. Open the SWK and TCRX stock pages for the full models.
Not investment advice.